ParAllele BioScience Products & Services


Overview Genotyping Services Genotyping Products Discovery Partnerships Ordering Support	Discovery Partnerships The ParAllele gene discovery partnerships provide the most comprehensive way for researchers to perform genetics studies. Our approach is tailored to individual study requirements, be it the study of all genetic variation in targeted regions or genome-wide association to discover disease genes or drug targets. Although other approaches are targeted primarily to the common disease common variation hypothesis, ParAllele studies the full spectrum of rare and common genetic variation to comprehensively identify both high and low relative risk alleles. Applications of our comprehensive approach include the following: Fine mapping of linkage peaks Candidate gene studies Gene discovery in the presence of allelic heterogeneity Genetics of clinical response (pharmacogenetics) The ParAllele advantage lies in our unprecedented approach to genetics that combines powerful, innovative technology with genetic and statistical expertise for optimal study design and data analysis. Our technology platform enables the comprehensive discovery and scoring of all genetic variation in cohorts and is easily scaled to cover the whole genome. Our team of world-class statisticians, molecular biologists, and bioinformaticians provides the multidisciplinary experience needed to unlock the most relevant genetics' data from patient cohorts. In addition, only our discovery partners have full access to our next-generation research tools, including the following: SNP variation scanning (to detect all germ line and somatic mutations) Quantitative genotyping Gene copy number Loss of heterozygosity Somatic mutation detection in tumors For more information about access to ParAllele Discovery Partnerships, please e-mail or call . top^
	All site contents Copyright © 2001-2004 ParAllele BioScience, Inc. All rights reserved.

Overview

Genotyping Services

Genotyping Products

Discovery Partnerships

Ordering

Support

Discovery Partnerships

The ParAllele gene discovery partnerships provide the most comprehensive way for researchers to perform genetics studies. Our approach is tailored to individual study requirements, be it the study of all genetic variation in targeted regions or genome-wide association to discover disease genes or drug targets. Although other approaches are targeted primarily to the common disease common variation hypothesis, ParAllele studies the full spectrum of rare and common genetic variation to comprehensively identify both high and low relative risk alleles.

Applications of our comprehensive approach include the following:

Fine mapping of linkage peaks
Candidate gene studies
Gene discovery in the presence of allelic heterogeneity
Genetics of clinical response (pharmacogenetics)

The ParAllele advantage lies in our unprecedented approach to genetics that combines powerful, innovative technology with genetic and statistical expertise for optimal study design and data analysis. Our technology platform enables the comprehensive discovery and scoring of all genetic variation in cohorts and is easily scaled to cover the whole genome. Our team of world-class statisticians, molecular biologists, and bioinformaticians provides the multidisciplinary experience needed to unlock the most relevant genetics' data from patient cohorts.

In addition, only our discovery partners have full access to our next-generation research tools, including the following:

SNP variation scanning (to detect all germ line and somatic mutations)
Quantitative genotyping
- Gene copy number
- Loss of heterozygosity
Somatic mutation detection in tumors

For more information about access to ParAllele Discovery Partnerships, please e-mail or call .

top^